A group of healthcare organizations released a report that includes recommendations for dealing with ongoing drug shortages in the United States, according to a Pharmaceutical-Journal report.
The group includes the American Hospital Association, American Society of Anesthesiologists, American Society of Clinical Oncology, American Society of Health-System Pharmacists, Institute for Safe Medication Practices and The Pew Charitable Trusts.
Some of the recommendations, according to the Pharmaceutical-Journal, include:
• Manufacturers should be allowed to sell trial batches of drugs that meet quality specifications to mitigate shortages.
• Pharmaceutical companies should be incentivised to invest in capacity and reliability to prevent supply disruptions.
• Regulatory review processes for plant upgrades and repairs needs to be sped up.
• Greater synchronisation is needed between the processes of international regulators.
The report is a result of a summit held in August 2014 comprising of the aforementioned groups.
More articles on ASC news:
Waldorf Endoscopy Center earns AAAHC accreditation
6 recent physician-owned ASC openings, plans
7 things for ASC leaders to know for Thursday